[Transperitoneal resorption of ampicillin, cefuroxim and gentamicin in continuous ambulatory peritoneal dialysis].

U. Thomae,W. Boos,D. Adam

1982-02-05

Abstract:

What problem does this paper attempt to address?

High performance liquid chromatographic determination of nine phenolic antioxidants in oils, lards, and shortenings.

B. Page

DOI: https://doi.org/10.1093/JAOAC/62.6.1239

1979-11-01

Abstract:A simple, rapid technique is described for the determination of 2- and 3-tert-butyl-4-hydroxyanisole (BHA), tert-butylhydroquinone (TBHQ), 3,5-di-tert-butyl-4-hydroxytoluene (BHT), 2,6-di-tert-butyl-4-hydroxymethylphenol (Ionox-100), 2,4,5-trihydroxybutyrophenone (THBP), propyl gallate (PG), octyl gallate (OG), dodecyl gallate (DG), and nordihydroguaiaretic acid (NDGA) in vegetable oils, lards, and shortenings. The antioxidants are partitioned from hexane-oil into acetonitrile, concentrated under vacuum, and determined by reverse phase, gradient elution, high performance liquid chromatography with detection at 280 nm. The mobile phase is water-acetonitrile with 5% acetic acid. With this system, only Ionox-100 and OG are not resolved. Recoveries from soya-sunflower seed oil spiked at 16 and 100 ppm and from lard at 32 ppm for 8 of the 9 antioxidants ranged from 96 to 103%, 100 to 102%, and 98 to 102%, respectively. The recoveries of BHT, due to incomplete extraction, were 84, 85, and 87%, respectively.
Artificial intelligence and inflammatory bowel disease: practicalities and future prospects

Johanne Brooks-Warburton,James Ashton,Anjan Dhar,Tony Tham,Patrick B Allen,Sami Hoque,Laurence B Lovat,Shaji Sebastian

DOI: https://doi.org/10.1136/flgastro-2021-102003

2021-12-10

Frontline Gastroenterology

Abstract:Artificial intelligence (AI) is an emerging technology predicted to have significant applications in healthcare. This review highlights AI applications that impact the patient journey in inflammatory bowel disease (IBD), from genomics to endoscopic applications in disease classification, stratification and self-monitoring to risk stratification for personalised management. We discuss the practical AI applications currently in use while giving a balanced view of concerns and pitfalls and look to the future with the potential of where AI can provide significant value to the care of the patient with IBD.
AI-luminating Artificial Intelligence in Inflammatory Bowel Diseases: A Narrative Review on the Role of AI in Endoscopy, Histology, and Imaging for IBD

Phillip Gu,Oreen Mendonca,Dan Carter,Shishir Dube,Paul Wang,Xiuzhen Huang,Debiao Li,Jason H Moore,Dermot P B McGovern

DOI: https://doi.org/10.1093/ibd/izae030

2024-03-07

Inflammatory Bowel Diseases

Abstract:Abstract Endoscopy, histology, and cross-sectional imaging serve as fundamental pillars in the detection, monitoring, and prognostication of inflammatory bowel disease (IBD). However, interpretation of these studies often relies on subjective human judgment, which can lead to delays, intra- and interobserver variability, and potential diagnostic discrepancies. With the rising incidence of IBD globally coupled with the exponential digitization of these data, there is a growing demand for innovative approaches to streamline diagnosis and elevate clinical decision-making. In this context, artificial intelligence (AI) technologies emerge as a timely solution to address the evolving challenges in IBD. Early studies using deep learning and radiomics approaches for endoscopy, histology, and imaging in IBD have demonstrated promising results for using AI to detect, diagnose, characterize, phenotype, and prognosticate IBD. Nonetheless, the available literature has inherent limitations and knowledge gaps that need to be addressed before AI can transition into a mainstream clinical tool for IBD. To better understand the potential value of integrating AI in IBD, we review the available literature to summarize our current understanding and identify gaps in knowledge to inform future investigations.

gastroenterology & hepatology
Artificial Intelligence and IBD: Where are We Now and Where Will We Be in the Future?

Mehwish Ahmed,Molly L Stone,Ryan W Stidham,Molly L. Stone,Ryan W. Stidham

DOI: https://doi.org/10.1007/s11894-024-00918-8

2024-02-28

Current Gastroenterology Reports

Abstract:Artificial intelligence (AI) is quickly demonstrating the ability to address problems and challenges in the care of IBD. This review with commentary will highlight today's advancements in AI applications for IBD in image analysis, understanding text, and replicating clinical knowledge and experience.
Artificial intelligence and inflammatory bowel disease: Where are we going?

Leonardo Da Rio,Marco Spadaccini,Tommaso Lorenzo Parigi,Roberto Gabbiadini,Arianna Dal Buono,Anita Busacca,Roberta Maselli,Alessandro Fugazza,Matteo Colombo,Silvia Carrara,Gianluca Franchellucci,Ludovico Alfarone,Antonio Facciorusso,Cesare Hassan,Alessandro Repici,Alessandro Armuzzi

DOI: https://doi.org/10.3748/wjg.v29.i3.508

IF: 5.374

2023-01-21

World Journal of Gastroenterology

Abstract:Inflammatory bowel diseases, namely ulcerative colitis and Crohn's disease, are chronic and relapsing conditions that pose a growing burden on healthcare systems worldwide. Because of their complex and partly unknown etiology and pathogenesis, the management of ulcerative colitis and Crohn's disease can prove challenging not only from a clinical point of view but also for resource optimization. Artificial intelligence, an umbrella term that encompasses any cognitive function developed by machines for learning or problem solving, and its subsets machine learning and deep learning are becoming ever more essential tools with a plethora of applications in most medical specialties. In this regard gastroenterology is no exception, and due to the importance of endoscopy and imaging numerous clinical studies have been gradually highlighting the relevant role that artificial intelligence has in inflammatory bowel diseases as well. The aim of this review was to summarize the most recent evidence on the use of artificial intelligence in inflammatory bowel diseases in various contexts such as diagnosis, follow-up, treatment, prognosis, cancer surveillance, data collection, and analysis. Moreover, insights into the potential further developments in this field and their effects on future clinical practice were discussed.

gastroenterology & hepatology
Artificial intelligence in endoscopy related to inflammatory bowel disease: A systematic review

Partha Pal,Kanapuram Pooja,Zaheer Nabi,Rajesh Gupta,Manu Tandan,Guduru Venkat Rao,Nageshwar Reddy

DOI: https://doi.org/10.1007/s12664-024-01531-3

Abstract:Background and objectives: In spite of rapid growth of artificial intelligence (AI) in digestive endoscopy in lesion detection and characterization, the role of AI in inflammatory bowel disease (IBD) endoscopy is not clearly defined. We aimed at systematically reviewing the role of AI in IBD endoscopy and identifying future research areas. Methods: We searched the PubMed and Embase database using keywords ("artificial intelligence" OR "machine learning" OR "computer-aided" OR "convolutional neural network") AND ("inflammatory bowel disease" OR "ulcerative colitis" OR "Crohn's") AND ("endoscopy" or "colonoscopy" or "capsule endoscopy" or "device assisted enteroscopy") between 1975 and September 2023 and identified 62 original articles for detailed review. Review articles, consensus guidelines, case reports/series, editorials, letter to the editor, non-peer-reviewed pre-prints and conference abstracts were excluded. The quality of the included studies was assessed using the MI-CLAIM checklist. Results: The accuracy of AI models (25 studies) to assess ulcerative colitis (UC) endoscopic activity ranged between 86.54% and 94.5%. AI-assisted capsule endoscopy reading (12 studies) substantially reduced analyzable images and reading time with excellent accuracy (90.5% to 99.9%). AI-assisted analysis of colonoscopic images can help differentiate IBD from non-IBD, UC from non-UC and UC from Crohn's disease (CD) (three studies) with 72.1%, 98.3% and > 90% accuracy, respectively. AI models based on non-invasive clinical and radiologic parameters could predict endoscopic activity (three studies). AI-assisted virtual chromoendoscopy (four studies) could predict histologic remission and long-term outcomes. Computer-assisted detection (CADe) of dysplasia (two studies) is feasible along with AI-based differentiation of high from low-grade IBD neoplasia (79% accuracy). AI is effective in linking electronic medical record data (two studies) with colonoscopic videos to facilitate widespread machine learning. Conclusion: AI-assisted IBD endoscopy has the potential to impact clinical management by automated detection and characterization of endoscopic lesions. Large, multi-center, prospective studies and commercially available IBD-specific endoscopic AI algorithms are warranted.
The Role of Artificial Intelligence in Monitoring Inflammatory Bowel Disease—The Future Is Now

Claudia Diaconu,Monica State,Mihaela Birligea,Madalina Ifrim,Georgiana Bajdechi,Teodora Georgescu,Bogdan Mateescu,Theodor Voiosu

DOI: https://doi.org/10.3390/diagnostics13040735

IF: 3.6

2023-02-16

Diagnostics

Abstract:Crohn's disease and ulcerative colitis remain debilitating disorders, characterized by progressive bowel damage and possible lethal complications. The growing number of applications for artificial intelligence in gastrointestinal endoscopy has already shown great potential, especially in the field of neoplastic and pre-neoplastic lesion detection and characterization, and is currently under evaluation in the field of inflammatory bowel disease management. The application of artificial intelligence in inflammatory bowel diseases can range from genomic dataset analysis and risk prediction model construction to the disease grading severity and assessment of the response to treatment using machine learning. We aimed to assess the current and future role of artificial intelligence in assessing the key outcomes in inflammatory bowel disease patients: endoscopic activity, mucosal healing, response to treatment, and neoplasia surveillance.

medicine, general & internal
Automated Endoscopic Diagnosis in IBD: The Emerging Role of Artificial Intelligence

Yasuharu Maeda,Shin-Ei Kudo,Takanori Kuroki,Marietta Iacucci

DOI: https://doi.org/10.1016/j.giec.2024.04.012

Abstract:The emerging role of artificial intelligence (AI) in automated endoscopic diagnosis represents a significant advancement in managing inflammatory bowel disease (IBD). AI technologies are increasingly being applied to endoscopic imaging to enhance the diagnosis, prediction of severity, and progression of IBD and dysplasia-associated colitis surveillance. These AI-assisted endoscopy aim to improve diagnostic accuracy, reduce variability of endoscopy imaging interpretations, and assist clinicians in decision-making processes. By leveraging AI, healthcare providers have the potential to offer more personalized and effective treatments, ultimately improving patient outcomes in IBD care.
Role of artificial intelligence in imaging and endoscopy for the diagnosis, monitoring and prognostication of inflammatory bowel disease: a scoping review protocol

Mallory Chavannes,Lynn Kysh,Mariangela Allocca,Noa Krugliak Cleveland,Michael Todd Dolinger,Tom S Robbins,David T Rubin,Shintaro Sagami,Bram Verstockt,Kerri Novak

DOI: https://doi.org/10.1136/bmjgast-2023-001182

2023-12-01

BMJ Open Gastroenterology

Abstract:Introduction Inflammatory bowel diseases (IBD) are immune-mediated conditions that are increasing in incidence and prevalence worldwide. Their assessment and monitoring are becoming increasingly important, though complex. The best disease control is achieved through tight monitoring of objective inflammatory parameters (such as serum and stool inflammatory markers), cross-sectional imaging and endoscopic assessment. Considering the complexity of the information obtained throughout a patient’s journey, artificial intelligence (AI) provides an ideal adjunct to existing tools to help diagnose, monitor and predict the course of disease of patients with IBD. Therefore, we propose a scoping review assessing AI’s role in diagnosis, monitoring and prognostication tools in patients with IBD. We aim to detect gaps in the literature and address them in future research endeavours. Methods and analysis We will search electronic databases, including Medline, Embase, Cochrane CENTRAL, CINAHL Complete, Web of Science and IEEE Xplore. Two reviewers will independently screen the abstracts and titles first and then perform the full-text review. A third reviewer will resolve any conflict. We will include both observational studies and clinical trials. Study characteristics will be extracted using a data extraction form. The extracted data will be summarised in a tabular format, following the imaging modality theme and the study outcome assessed. The results will have an accompanying narrative review. Ethics and dissemination Considering the nature of the project, ethical review by an institutional review board is not required. The data will be presented at academic conferences, and the final product will be published in a peer-reviewed journal.
EFFECT OF HIGH DOSES OF CORTISONE ON BONE MARROW CELL PROLIFERATION IN THE SYRIAN HAMSTER.

G. Cardinali,B. DeCaro,A. Handler,M. Aboul-Enein

IF: 11.2

1964-07-01

Cancer Research

Abstract:Summary Bone marrow cell proliferation was studied in Syrian hamsters treated with high doses of cortisone. Mitotic index after metaphase arrest of dividing cells was used to evaluate cell proliferation changes. Vinblastine was employed as the metaphasearresting agent. Within a few hours following the administration of a high dose of cortisone there was marked reduction of bone marrow cell proliferation. The lowest value of mitotic index was observed at the 12th hour. At the 24th hour the mitotic index increased somewhat above the normal and then returned to normal. The scoring of mitoses separately in the myeloid and erythroid series showed that mitotic activity was depressed in both series during the first 12–18 hours after administration of high doses of cortisone.
Artificial intelligence: A new tool in the pathologist's armamentarium for the diagnosis of IBD

Anna Lucia Cannarozzi,Luca Massimino,Anna Latiano,Tommaso Lorenzo Parigi,Francesco Giuliani,Fabrizio Bossa,Anna Laura Di Brina,Federica Ungaro,Giuseppe Biscaglia,Silvio Danese,Francesco Perri,Orazio Palmieri

DOI: https://doi.org/10.1016/j.csbj.2024.09.003

2024-09-11

Abstract:Inflammatory bowel diseases (IBD) are classified into two entities, namely Crohn's disease (CD) and ulcerative colitis (UC), which differ in disease trajectories, genetics, epidemiological, clinical, endoscopic, and histopathological aspects. As no single golden standard modality for diagnosing IBD exists, the differential diagnosis among UC, CD, and non-IBD involves a multidisciplinary approach, considering professional groups that include gastroenterologists, endoscopists, radiologists, and pathologists. In this context, histological examination of endoscopic or surgical specimens plays a fundamental role. Nevertheless, in differentiating IBD from non-IBD colitis, the histopathological evaluation of the morphological lesions is limited by sampling and subjective human judgment, leading to potential diagnostic discrepancies. To overcome these limitations, artificial intelligence (AI) techniques are emerging to enable automated analysis of medical images with advantages in accuracy, precision, and speed of investigation, increasing interest in the histological analysis of gastrointestinal inflammation. This review aims to provide an overview of the most recent knowledge and advances in AI methods, summarizing its applications in the histopathological analysis of endoscopic biopsies from IBD patients, and discussing its strengths and limitations in daily clinical practice.
Artificial Intelligence in Inflammatory Skin Disorders

Ghasem Rahmatpour Rokni,Nasim Gholizadeh,Mahsa Babaei,Kinnor Das,Shainee Datta

DOI: https://doi.org/10.1002/der2.243

2024-06-01

Dermatological Reviews

Abstract:Abstract Background The integration of artificial intelligence (AI) in dermatology is revolutionizing the diagnostic methods and management strategies and hence is uplifting the overall patient care. AI technologies have shown a significant potential in automated diagnosis, severity assessment of chronic cutaneous diseases like psoriasis, and the development of comprehensive dermatological databases is helping in swift disease detection. Objective This review aims to explore the current landscape and future potential of AI in inflammatory skin diseases. It focuses on various automated diagnostic systems, the role of AI in assessment and staging of chronic inflammatory dermatological conditions, and the importance of dermatological databases. The review also addresses the various challenges associated with AI implementation. Methods A extensive literature search was conducted from databases namely, PubMed, Google Scholar, and Embase. Search terms included combinations of “artificial intelligence,” “deep learning,” “dermatology,” “automated diagnosis,” and “dermatological databases” from different field of study. Articles were selected and reviewed based on relevance and quality, highlighting studies demonstrating AI's impact on diagnosis and management. Results AI‐powered diagnostic systems have ominously advanced, offering noninvasive and accessible diagnostic tool(s) that use extensive datasets to improve accuracy and efficacy across different populations. The development of dermatological databases is fundamental for training of different AI models. Despite these advances, challenges related to data privacy, regulatory oversight, and inclusivity in AI models persist. Addressing these challenges is essential for augmenting and optimizing AI's potential in dermatology. Conclusion AI is set to transmute dermatology by augmenting diagnostic precision, customizing treatment plans, and making dermatological care more reachable, particularly in underprivileged areas. This review highlights the various advances made in AI for the diagnosis and management of inflammatory skin disorders, acknowledging the ethical and technical hurdles that need to be addressed.
Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion

Philippe Pinton

DOI: https://doi.org/10.1080/07853890.2023.2300670

IF: 5.348

2024-01-03

Annals of Medicine

Abstract:Introduction Artificial intelligence (AI) is expected to impact all facets of inflammatory bowel disease (IBD) management, including disease assessment, treatment decisions, discovery and development of new biomarkers and therapeutics, as well as clinician–patient communication.

medicine, general & internal
Application of artificial intelligence in gastroenterology: Potential role in clinical practice

Chen-Ya Kuo,Han-Mo Chiu

DOI: https://doi.org/10.1111/jgh.15403

Abstract:Artificial intelligence (AI) based on deep learning boosted medical research in the past years and is expected to enormously change the style of health care in many aspects in the foreseeable future. Nowadays, there are exploding volumes of healthcare-related data being generated daily. Because of its time-sensitive characteristics, being able to process large amounts of data in real-time fashion is crucial in healthcare settings. In gastroenterology practice, AI can manage and interpret the sheer amount of data with different formats coming from a myriad of sources, including currently used endoscopic or imaging devices, digital record systems, and electronic health records, or from other sources such as governmental databases, social media, or wearable devices over a long period. Traditional gastroenterology is nowadays beginning to transform to a new personalized, predictive, and preventive paradigm. Evidence-based practices and recent studies are coming out every day, and big data-based approaches and the progress in basic sciences and its emerging applications are now becoming the indispensable part of precision medicine. In gastroenterology, AI can be applied in disease diagnosis, treatment guidance, outcome prediction, and reducing workload of the healthcare staff. As the healthcare community begins to embrace AI technology, how to seamlessly construct an interoperable platform to accommodate data with high variety and veracity with high velocity and implement AI in the clinical workflow would be the future challenges.
Artificial intelligence in gastroenterology: A state-of-the-art review

Paul T Kröner,Megan Ml Engels,Benjamin S Glicksberg,Kipp W Johnson,Obaie Mzaik,Jeanin E van Hooft,Michael B Wallace,Hashem B El-Serag,Chayakrit Krittanawong

DOI: https://doi.org/10.3748/wjg.v27.i40.6794

2021-10-28

Abstract:The development of artificial intelligence (AI) has increased dramatically in the last 20 years, with clinical applications progressively being explored for most of the medical specialties. The field of gastroenterology and hepatology, substantially reliant on vast amounts of imaging studies, is not an exception. The clinical applications of AI systems in this field include the identification of premalignant or malignant lesions (e.g., identification of dysplasia or esophageal adenocarcinoma in Barrett's esophagus, pancreatic malignancies), detection of lesions (e.g., polyp identification and classification, small-bowel bleeding lesion on capsule endoscopy, pancreatic cystic lesions), development of objective scoring systems for risk stratification, predicting disease prognosis or treatment response [e.g., determining survival in patients post-resection of hepatocellular carcinoma), determining which patients with inflammatory bowel disease (IBD) will benefit from biologic therapy], or evaluation of metrics such as bowel preparation score or quality of endoscopic examination. The objective of this comprehensive review is to analyze the available AI-related studies pertaining to the entirety of the gastrointestinal tract, including the upper, middle and lower tracts; IBD; the hepatobiliary system; and the pancreas, discussing the findings and clinical applications, as well as outlining the current limitations and future directions in this field.
Total joint replacement in digits of the foot.

J. Silberman,I. Kanat

1984-05-01

Abstract:Digital deformities present one of the most common entities seen by the podiatric physician today. Surgical correction of these deformities has historically centered upon the "arthroplasty" or phalangeal head resection, but the advent of Silastic implants that replace the interphalangeal joints of the lesser digits may improve the results of revision arthroplasties or severely arthritic joints. This paper will present two types of lesser digital implants that have successfully been used when the proper indications are met.
Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence

Anna Lucia Cannarozzi,Anna Latiano,Luca Massimino,Fabrizio Bossa,Francesco Giuliani,Matteo Riva,Federica Ungaro,Maria Guerra,Anna Laura Di Brina,Giuseppe Biscaglia,Francesca Tavano,Sonia Carparelli,Gionata Fiorino,Silvio Danese,Francesco Perri,Orazio Palmieri

DOI: https://doi.org/10.1002/ueg2.12655

2024-08-31

Abstract:Various extrinsic and intrinsic factors such as drug exposures, antibiotic treatments, smoking, lifestyle, genetics, immune responses, and the gut microbiome characterize ulcerative colitis and Crohn's disease, collectively called inflammatory bowel disease (IBD). All these factors contribute to the complexity and heterogeneity of the disease etiology and pathogenesis leading to major challenges for the scientific community in improving management, medical treatments, genetic risk, and exposome impact. Understanding the interaction(s) among these factors and their effects on the immune system in IBD patients has prompted advances in multi-omics research, the development of new tools as part of system biology, and more recently, artificial intelligence (AI) approaches. These innovative approaches, supported by the availability of big data and large volumes of digital medical datasets, hold promise in better understanding the natural histories, predictors of disease development, severity, complications and treatment outcomes in complex diseases, providing decision support to doctors, and promising to bring us closer to the realization of the "precision medicine" paradigm. This review aims to provide an overview of current IBD omics based on both individual (genomics, transcriptomics, proteomics, metagenomics) and multi-omics levels, highlighting how AI can facilitate the integration of heterogeneous data to summarize our current understanding of the disease and to identify current gaps in knowledge to inform upcoming research in this field.
Artificial Intelligence in Small Bowel Endoscopy: Current Perspectives and Future Directions

Dinesh Meher,Mrinal Gogoi,Pankaj Bharali,Prajna Anirvan,Shivaram Singh,Shivaram Prasad Singh

DOI: https://doi.org/10.1055/s-0040-1717824

2020-10-08

Journal of Digestive Endoscopy

Abstract:Abstract Artificial intelligence (AI) is a computer system that is able to perform tasks which normally require human intelligence. The role of AI in the field of gastroenterology has been gradually evolving since its inception in the 1950s. Discovery of wireless capsule endoscopy (WCE) and balloon enteroscopy (BE) has revolutionized small gut imaging. While WCE is a relatively patient-friendly and noninvasive mode to examine the nonobstructed small gut, it is limited by a lengthy examination time and the need for expertise in reading images acquired by the capsule. Similarly, BE, despite having the advantage of therapeutic intervention, is costly, invasive, and requires general sedation. Incorporation of concepts like machine learning and deep learning has been used to handle large amounts of data and images in gastroenterology. Interestingly, in small gut imaging, the application of AI has been limited to WCE only. This review was planned to examine and summarize available published data on various AI-based approaches applied to small bowel disease. We conducted an extensive literature search using Google search engine, Google Scholar, and PubMed database for published literature in English on the application of different AI techniques in small bowel endoscopy, and have summarized the outcome and benefits of these applications of AI in small bowel endoscopy. Incorporation of AI in WCE has resulted in significant advancements in the detection of various lesions starting from dysplastic mucosa, inflammatory and nonmalignant lesions to the detection of bleeding with increasing accuracy and has shortened the lengthy review time in image analysis. As most of the studies to evaluate AI are retrospective, the presence of inherent selection bias cannot be excluded. Besides, the interpretability (black-box nature) of AI models remains a cause for concern. Finally, issues related to medical ethics and AI need to be judiciously addressed to enable its seamless use in future.
The Role of Artificial Intelligence in the Diagnosis and Treatment of Ulcerative Colitis

Petar Uchikov,Usman Khalid,Nikola Vankov,Maria Kraeva,Krasimir Kraev,Bozhidar Hristov,Milena Sandeva,Snezhanka Dragusheva,Dzhevdet Chakarov,Petko Petrov,Bistra Dobreva-Yatseva,Ivan Novakov

DOI: https://doi.org/10.3390/diagnostics14101004

IF: 3.6

2024-05-14

Diagnostics

Abstract:Background and objectives: This review aims to delve into the role of artificial intelligence in medicine. Ulcerative colitis (UC) is a chronic, inflammatory bowel disease (IBD) characterized by superficial mucosal inflammation, rectal bleeding, diarrhoea and abdominal pain. By identifying the challenges inherent in UC diagnosis, we seek to highlight the potential impact of artificial intelligence on enhancing both diagnosis and treatment methodologies for this condition. Method: A targeted, non-systematic review of literature relating to ulcerative colitis was undertaken. The PubMed and Scopus databases were searched to categorize a well-rounded understanding of the field of artificial intelligence and its developing role in the diagnosis and treatment of ulcerative colitis. Articles that were thought to be relevant were included. This paper only included articles published in English. Results: Artificial intelligence (AI) refers to computer algorithms capable of learning, problem solving and decision-making. Throughout our review, we highlighted the role and importance of artificial intelligence in modern medicine, emphasizing its role in diagnosis through AI-assisted endoscopies and histology analysis and its enhancements in the treatment of ulcerative colitis. Despite these advances, AI is still hindered due to its current lack of adaptability to real-world scenarios and its difficulty in widespread data availability, which hinders the growth of AI-led data analysis. Conclusions: When considering the potential of artificial intelligence, its ability to enhance patient care from a diagnostic and therapeutic perspective shows signs of promise. For the true utilization of artificial intelligence, some roadblocks must be addressed. The datasets available to AI may not truly reflect the real-world, which would prevent its impact in all clinical scenarios when dealing with a spectrum of patients with different backgrounds and presenting factors. Considering this, the shift in medical diagnostics and therapeutics is coinciding with evolving technology. With a continuous advancement in artificial intelligence programming and a perpetual surge in patient datasets, these networks can be further enhanced and supplemented with a greater cohort, enabling better outcomes and prediction models for the future of modern medicine.

medicine, general & internal
Perioperative morbidity and mortality in patients treated by radical cystectomy: A multi-institutional retrospective study.

N. Takada,T. Abe,S. Maruyama,A. Sazawa,N. Shinohara,T. Seki,M. Togashi,K. Nonomura

DOI: https://doi.org/10.1200/JCO.2011.29.7_SUPPL.270

IF: 45.3

2011-03-01

Journal of Clinical Oncology

Abstract:270 Background: It is well known that radical cystectomy is associated with comparatively high perioperative morbidity and mortality. In the present study, we collected data of perioperative outcomes from Hokkaido University Graduate School of Medicine and our teaching hospitals and assessed the complications and death rate within 90 days after radical cystectomy. METHODS We collected clinical data of 970 patients undergoing radical cystectomy for nonmetastatic bladder cancer in 21 institutions between 1999 and 2009. We then assessed 90-day complications and death after radical cystectomy. The complications were classified according to the modified Clavien classification. Over 40 variables were included in the analysis, including age, ASA score, BMI, comorbidity, neoadjuvant chemotherapy, clinical stage, type of urinary diversion, operative time, estimated blood loss, transfusion, and hospital stay. Statistical analysis was performed utilizing Student's t-tests, chi-square tests, and logistic regression analysis. RESULTS The median patient age was 70 (range, 25-91) years old. 62.5% of patients had an ASA score≥2. Regarding the urinary diversion, ileal conduit was performed in 523 (53.6%) patients, neobladder in 178 (18.4%), ureterocutaneostomy in 255 (26.3%). Median operative time was 399 (range, 100-927) minutes. Median hospital stay was 39 (0-364) days. Regarding the complications, 660 (68%) patients experienced at least one complication and death rate within 90 days after surgery was 1.34% (n=13), respectively. Of the complications, 34.1% was classified as grade 1, 41.5% as grade 2, 20.1% as grade 3, 1.1% as grade 4, 1.2% as grade 5. Multivariate analysis identified age≥70 (odds ratio 1.41), urinary diversion utilizing intestine (OR 1.58) and operative time ≥ 400 (OR 1.54) were independent risk factors. CONCLUSIONS Death rate was 1.34%, which was compatible to reports form western high- volume centers. About two-thirds of the patients experienced at least one complication, although they were mostly classified as grade 2 or less. Age, urinary diversion, and operative time were significant risk factors for perioperative complications after radical cystectomy. No significant financial relationships to disclose.

[Transperitoneal resorption of ampicillin, cefuroxim and gentamicin in continuous ambulatory peritoneal dialysis].

High performance liquid chromatographic determination of nine phenolic antioxidants in oils, lards, and shortenings.

Artificial intelligence and inflammatory bowel disease: practicalities and future prospects

AI-luminating Artificial Intelligence in Inflammatory Bowel Diseases: A Narrative Review on the Role of AI in Endoscopy, Histology, and Imaging for IBD

Artificial Intelligence and IBD: Where are We Now and Where Will We Be in the Future?

Artificial intelligence and inflammatory bowel disease: Where are we going?

Artificial intelligence in endoscopy related to inflammatory bowel disease: A systematic review

The Role of Artificial Intelligence in Monitoring Inflammatory Bowel Disease—The Future Is Now

Automated Endoscopic Diagnosis in IBD: The Emerging Role of Artificial Intelligence

Role of artificial intelligence in imaging and endoscopy for the diagnosis, monitoring and prognostication of inflammatory bowel disease: a scoping review protocol

EFFECT OF HIGH DOSES OF CORTISONE ON BONE MARROW CELL PROLIFERATION IN THE SYRIAN HAMSTER.

Artificial intelligence: A new tool in the pathologist's armamentarium for the diagnosis of IBD

Artificial Intelligence in Inflammatory Skin Disorders

Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion

Application of artificial intelligence in gastroenterology: Potential role in clinical practice

Artificial intelligence in gastroenterology: A state-of-the-art review

Total joint replacement in digits of the foot.

Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence

Artificial Intelligence in Small Bowel Endoscopy: Current Perspectives and Future Directions

The Role of Artificial Intelligence in the Diagnosis and Treatment of Ulcerative Colitis

Perioperative morbidity and mortality in patients treated by radical cystectomy: A multi-institutional retrospective study.